PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients
Clinical trial NCT03064854 · TERMINATED
Trial details
- NCT number
- NCT03064854
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-24
- Primary completion
- 2021-07-28
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.